Bausch Health Companies Inc
Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company, develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, generic pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health in the United States and internationally. The company operates throu… Read more
Bausch Health Companies Inc - Asset Resilience Ratio
Bausch Health Companies Inc (BHC) has an Asset Resilience Ratio of 6.33% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (1999–2024)
This chart shows how Bausch Health Companies Inc's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Bausch Health Companies Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $1.73 Billion | 6.33% |
| Short-term Investments | $0.00 | 0% |
| Total Liquid Assets | $1.73 Billion | 6.33% |
Asset Resilience Insights
- Limited Liquidity: Bausch Health Companies Inc maintains only 6.33% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Bausch Health Companies Inc Industry Peers by Asset Resilience Ratio
Compare Bausch Health Companies Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF |
Drug Manufacturers - Specialty & Generic | -0.02% |
|
Kamada
NASDAQ:KMDA |
Drug Manufacturers - Specialty & Generic | 21.63% |
|
Dongwha Pharm.Co.Ltd
KO:000020 |
Drug Manufacturers - Specialty & Generic | 1.92% |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078 |
Drug Manufacturers - Specialty & Generic | 0.46% |
|
Yuhan Corp.
KO:000100 |
Drug Manufacturers - Specialty & Generic | 0.99% |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153 |
Drug Manufacturers - Specialty & Generic | 1.81% |
|
Kotra Industries Bhd
KLSE:0002 |
Drug Manufacturers - Specialty & Generic | 9.82% |
|
Yuyu Pharma Inc
KO:000227 |
Drug Manufacturers - Specialty & Generic | 1.74% |
Annual Asset Resilience Ratio for Bausch Health Companies Inc (1999–2024)
The table below shows the annual Asset Resilience Ratio data for Bausch Health Companies Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 4.45% | $1.18 Billion | $26.52 Billion | +0.99pp |
| 2023-12-31 | 3.46% | $947.00 Million | $27.35 Billion | +1.27pp |
| 2022-12-31 | 2.20% | $564.00 Million | $25.69 Billion | +0.20pp |
| 2021-12-31 | 1.99% | $582.00 Million | $29.20 Billion | +0.05pp |
| 2020-12-31 | 1.94% | $605.00 Million | $31.20 Billion | -7.64pp |
| 2019-12-31 | 9.58% | $3.24 Billion | $33.86 Billion | +6.95pp |
| 2018-12-31 | 2.63% | $721.00 Million | $27.45 Billion | +0.50pp |
| 2017-12-31 | 2.13% | $797.00 Million | $37.50 Billion | +0.88pp |
| 2016-12-31 | 1.25% | $543.00 Million | $43.53 Billion | +1.21pp |
| 2015-12-31 | 0.03% | $16.00 Million | $48.96 Billion | -0.13pp |
| 2014-12-31 | 0.16% | $43.00 Million | $26.35 Billion | +0.07pp |
| 2013-12-31 | 0.09% | $25.20 Million | $27.97 Billion | +0.07pp |
| 2012-12-31 | 0.02% | $4.41 Million | $17.95 Billion | -0.02pp |
| 2011-12-31 | 0.05% | $6.34 Million | $13.14 Billion | -0.01pp |
| 2010-12-31 | 0.06% | $6.08 Million | $10.80 Billion | -0.41pp |
| 2009-12-31 | 0.46% | $9.57 Million | $2.07 Billion | +0.40pp |
| 2008-12-31 | 0.06% | $997.00K | $1.62 Billion | -0.16pp |
| 2007-12-31 | 0.22% | $3.90 Million | $1.78 Billion | +0.20pp |
| 2005-12-31 | 0.02% | $511.00K | $2.19 Billion | -0.23pp |
| 2004-12-31 | 0.25% | $5.02 Million | $2.01 Billion | -10.13pp |
| 1999-12-31 | 10.38% | $65.90 Million | $635.10 Million | -- |